![Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and](https://ars.els-cdn.com/content/image/1-s2.0-S0002870317301242-gr1.jpg)
Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and
![PDF) Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease PDF) Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease](https://i1.rgstatic.net/publication/264500881_Low-Dose_Aspirin_for_Prevention_of_Cardiovascular_Disease_in_Patients_with_Chronic_Kidney_Disease/links/55deb76a08ae45e825d3a3fb/largepreview.png)
PDF) Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
![The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-92753-4/MediaObjects/41598_2021_92753_Fig1_HTML.png)
The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports
![Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study | SpringerLink Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40620-022-01441-7/MediaObjects/40620_2022_1441_Figa_HTML.png)
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study | SpringerLink
Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease | PLOS ONE
![Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S008525382030973X-fx1.jpg)
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect
![Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease - ScienceDirect Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253822008481-fx1.jpg)
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease - ScienceDirect
![Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease | Scientific Reports Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22474-9/MediaObjects/41598_2022_22474_Fig1_HTML.png)
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease | Scientific Reports
![THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND CHRONIC KIDNEY DISEASE | Journal of the American College THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND CHRONIC KIDNEY DISEASE | Journal of the American College](https://www.jacc.org/cms/asset/d2378f98-1b08-4646-aeb6-58429de0f420/s0735-1097(22)02026-5.fp.png)
THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND CHRONIC KIDNEY DISEASE | Journal of the American College
![Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke - ScienceDirect Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0953620516304058-gr1.jpg)
Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke - ScienceDirect
![Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population - Renal and Urology News Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population - Renal and Urology News](https://www.renalandurologynews.com/wp-content/uploads/sites/22/2019/01/gaspirinweb_1363362.jpg)